|
|
|||||
|
|
|
||||
|
March 2005 In the February issue of Infectious Disease News was a brief article about the identification of an apparently new strain of human coronaviruses that caused respiratory disease in children and an apparent relationship to the subsequent occurrence of Kawasaki disease (KD). The work was carried out at the Yale University School of Medicine; hence the coronavirus strain was identified as the New Haven strain, or HCoV-NH. Since most of us as adult ID physicians are generally unfamiliar with a number of pediatric ID issues, including KD and its diagnosis and management, it seems appropriate to explore this new association more fully. The only exception to the previous generalization would likely be those among us who find themselves providing infectious disease consultation to pediatricians. (It would be of interest to know what proportion of adult ID physicians actually do that.) The key articles reporting this work are by Frank Esper, MD, and a number of colleagues at Yale and are reported in the Journal of Infectious Diseases (2005; 191[4)]:492-502). In addition, interested readers should review the accompanying editorial by Kenneth McIntosh, MD, of Harvard Medical School, found on pages 489-491 of the same issue.
|
|
KD, for those not fully familiar with this entity, is a systemic vasculitis of children that in its most serious manifestation results in aneurysms of the coronary arteries. It is said to be the most common cause of acquired heart disease in children, at least in the developed world, a title probably once held by rheumatic fever. Classic KD is defined as fever for five or more days, plus four of five of the following: (1) bilateral conjunctivitis; (2) erythema of the mouth or pharynx, strawberry tongue or stomatitis; (3) polymorphous rash; (4) erythema or edema of the hands or feet; and (5) nonsuppurative cervical lymphadenopathy. Alternatively, the diagnosis is also established if three of the criteria are met and there is evidence of coronary artery abnormalities.
The epidemiology of KD suggests a response to a respiratory infectious agent. For example, it tends to occur in the winter and spring months; it is rare in infants older than 3 months, suggesting protection by passively acquired maternal antibody; and it is often preceded by an apparent respiratory infection. A number of respiratory agents have been proposed in the past, including an unidentified retrovirus, parvovirus B19, Epstein-Barr virus, Chlamydia pneumoniae, toxin-producing Staphylococcus aureus or Streptococcus pyogenes and a few others as well. McIntosh points out in his editorial comments that the statistical strength of the initial association reported for several of these possible etiologies was almost as strong as that reported by Esper and his colleagues. None, however, have stood the tests of time and reproducibility by others in different locations.
McIntosh goes on to cite several reasons why the current coronavirus association may prove to be real. In addition to the epidemiologic evidence, immunopathologic studies have suggested that during the course of KD, some external agent causes a powerful immunoglobulin A (IgA) response in the respiratory tract, as well as in other organs, suggesting a response to a specific microbial infection. Finally, he pointed out the enormous size of the coronavirus genome, capable of producing highly varied pathogenic effects in both animals and man. He thus felt that there are reasons to be at least guardedly optimistic about the Yale findings.
Even if the coronavirus association proves to be correct, there is still much research yet to be done to understand the immunopathologic processes that lead to KD. Is it directly caused by the virus; is it an abnormal host response to the virus; is there an intermediate process involved? This promises to be a fascinating area as further research unfolds, so stay tuned!
![]()